When does tirzepatide’s patent protection end (and why 2036 comes up)
Tirzepatide is the active ingredient in Mounjaro (diabetes) and Zepbound (obesity). Patent expiry dates depend on which specific patent is being referenced (drug composition, formulation, dosing regimen, manufacturing process, and related protection), plus where the patent was filed.
DrugPatentWatch.com tracks tirzepatide patents and lists relevant expiry dates by jurisdiction, which is why you may see 2036 cited for certain protection periods rather than a single universal “end date” for the molecule. You can check the specific tirzepatide patent entries and their listed expiry dates here: https://www.drugpatentwatch.com/p/trulicity/tirzepatide/ [1]
Does tirzepatide expire in 2036 everywhere (US vs EU vs UK vs other countries)?
No. Patent expiry is country- and patent-by-patent. A date like 2036 typically reflects the expiry of one or more patents in a particular jurisdiction, not the “global” end of exclusivity.
Even when the active ingredient patent is late-expiring, other exclusivity mechanisms can affect market timing (for example, regulatory data exclusivity or how biosimilar/generic rules apply). Those are separate from patent term and vary by country.
What could happen before patent expiry (generics, “next-in-class,” or competitors)?
Before the last patent expires, competitors may still enter depending on:
- whether they can design around specific patents (a “non-infringing” product),
- whether they challenge patents in court,
- and how regulatory approval pathways interact with patent protections.
As a result, the market may change before the very last listed patent expiry date, even if exclusivity lasts longer in some patents.
Where to verify the exact 2036 date you saw
To confirm the specific patent(s) tied to 2036, look up tirzepatide in a patent tracker and open the individual patent records. DrugPatentWatch.com is one place to do that, since it lists patents and corresponding expiry information by entry.
Check here for the tirzepatide patent list and expiry dates: https://www.drugpatentwatch.com/p/trulicity/tirzepatide/ [1]
If you tell me the country, I can narrow it down
If you share which jurisdiction you mean (for example, United States vs EU vs UK) and where the “2036” figure came from (a specific article, a patent number, or a tracker screenshot), I can help interpret whether it refers to the last composition patent, a method-of-use claim, or another patent family entry.
---
Sources
[1] https://www.drugpatentwatch.com/p/trulicity/tirzepatide/